Kwee Yong is Professor of Haematology at University College London where she leads the multiple myeloma programme. She is a member of the UK Myeloma Research Alliance senior leadership team, and leads national studies in multiple myeloma, ranging from Phase 3 trials to first-in-human trials of novel therapies. She runs a laboratory programme working on aspects of myeloma biology, immune environment and translational strategies including CAR T-cell therapies. A particular focus is the contribution of immune dysfunction to clinical outcomes including progression from precursor disease. The programme receives funding from the Medical Research Council UK, Cancer Research UK and Blood Cancer UK. Professor Yong has published over 150 original papers in peer-reviewed journals.
EM-89025 - Date of preparation: February 2022